AXSM News and Press, Axsome Therapeutics Inc. From 02/07/23

NEW YORK, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that Herriot Tabuteau, MD, Axsome’s Chief Executive Offi...

NEW YORK, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that it will report its financial results for the fourth quarte...

Long-term investors looking to overcome the effects of inflation can find some satisfaction from quality growth stocks , especially from companies generating triple-digit growth in revenue and share-price appreciation. Shares of Inspire Medical Systems (NYSE: INSP) , Axsome Ther...

Summary Healthcare significantly outperformed the broader market last year, after two years of underperforming the S&P 500. When the end to restrictive policy is in sight, then the sector is likely to witness a group rotation to more growth-oriented stocks. Groups like medical d...

Last year's market wasn't gloomy for every company. Investors bought certain stocks hand over fist. In most cases, these particular companies offered investors a solid reason to be optimistic about their future. And that's why they were able to defy the bear market. I can easily think of thre...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Editor’s note: “A Golden Ticket to Beat the Fed and Profit in ‘Hidden Bull Markets’ ” was previously published in August 2022 . It has since been updated to include the most relevant info...

Summary Federal Reserve interest rate policy to again remain the market focus this year and create a chaotic first half. Biotechnology should be favorably positioned relative to the market if the economy slips into a recession. Biotech fortunes near term are to be determined by the ...

Earning outsize returns in the stock market over a short period can be exciting, but doing so over the long run is even better. Can some companies provide both? Yes, especially those relatively small corporations that have yet to become household names. After all, many currently well-established ...

Markets were tough last year for most stocks -- and investors. But some companies managed to beat the bear market. Two biotechs, in particular, shined for very good reasons. Axsome Therapeutics (NASDAQ: AXSM) soared more than 100%. And Vertex Pharmaceuticals (NASDAQ: VRTX) advance...

Summary TG Therapeutics, Inc. is set to launch Briumvi with an experienced in-house team. There are several factors conducive to launch success. Nevertheless, uncertainty remains. If TG Therapeutics can secure a sales/marketing partnership, the company will likely make a successful ...